Natural Products as Anti-Cancer Drugs

Dietary sources of natural products are assumed to have anti-cancer benefits include fruits, vegetables and spices yielding biologically active components such as curcumin, resveratrol, cucurbitacins, isoflavones, saponins, phytosterols, lycopene, and many others. A number of these are gaining importance as adjuvant anti-cancer agents with curcumin, resveratrol and cucurbitacins having activity reported against cancer stem cells.  39 natural compounds from marine species, mostly invertebrates, and 10 from microorganisms, mostly from bacteria of the Streptomyces genus, as potential new anti-cancer agents. It is assumed that many prokaryotic and eukaryotic natural product sources may still reveal a number of valuable anti-cancer compounds in the future and even ancient animal species have been suggested as a particularly valuable source.

Cancer is a well-recognized global health problem responsible for 7.6 million deaths (13% of all deaths) worldwide, which is expected to rise to 13.1 million by 2030 Despite the progress in the field of cancer research, both developing and developed countries are in the grip of this deadly disease, and still there is a need to discover and develop anti-cancer therapeutic agents. It has long been recognized that natural products represent the richest source of high chemical diversity, providing the basis for identification of novel scaffold structures that serves as starting points for rational drug design. This can be one of the reasons that efforts have been directed to discover promising cancer therapeutic agents from natural sources. Over the years, many natural product-based drugs have been introduced in the market. According to a recent review, 49% of drugs were either natural products or their derivatives that are used in cancer treatment. Moreover, between the year 2005 and 2010, 19 natural product-based drugs have been approved, among which 7, 10 and 2 have been classified as natural product (NP), semi-synthetic NPs and NP-derived drugs, respectively. Of these, five drugs, temsirolimus, trabectedin, ixabepilone, everolimus and romidepsin, have been developed in the area of oncology from 2007 to 2009. Indeed, it has been suggested that less than one-fifth of the ring systems found in natural products are represented in current trade drugs 

  • Marine organisms having antineoplastic activity
  • Potent alkaloidal neurotoxins
  • Polyketide neurotoxins
  • Preclinical anticancer lead compounds
  • Multitude of mixed biogenesis metabolites
  • In vitro and in vivo anticancer and antioxidant assays

Related Conference of Natural Products as Anti-Cancer Drugs

August 31-September 01, 2017,

3rd International Conference on Biopharmaceutics and Biologic Drugs

Philadelphia, USA
(10 Plenary Forums - 1Event)
August 31-September 01, 2017

5th International Pharmacy Conference


(10 Plenary Forums - 1 Event)
Philadelphia, USA
September 04-06, 2017

9th World Congress on Pharmacology

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trials

San Antonio, Texas, USA
(10 Plenary Forums - 1 Event)
September 11-12, 2017

World Congress on Biotherapeutics and Bioanalytical Techniques

(10 Plenary Forums - 1Event) Dallas, Texas, USA
September 18-19, 2017

6th International Conference on Forensic Research & Technology

(10 Plenary Forums - 1Event)
Houston, Texas, USA
Sep 25-26, 2017

12th Annual
Pharma Middle East Congress

Dubai, UAE
October 02-03, 2017

9th Annual Pharmaceutical Chemical Analysis Congress

Vienna, Austria
October 16-17, 2017

16th Annual Medicinal & Pharmaceutical Sciences Congress

Seoul, South Korea
October 16-18, 2017
(10 Plenary Forums - 1 Event)

4th International Conference on Past and Present Research Systems of Green Chemistry

Atlanta, Georgia, USA
October 18-19, 2017

6th Global Congress on Mass Spectrometry

Osaka, Japan
October 19-20, 2017

9th Annual Congress on Drug Design & Drug Formulation

Seoul, South Korea
October 19-20, 2017

4th International Conference and Exhibition on Pain Medicine

(10 Plenary Forums - 1 Event)
San Francisco, California, USA
(10 Plenary Forums - 1 Event) October 23-24, 2017

5th International Conference on Clinical Pharmacy and Healthcare IT

Orlando, Florida, USA
October 30-November 01, 2017
A B2B Networking & Global Knowledge Exchange Forum

Annual Congress on Emerging Orphan Drugs and  Rare Diseases

San Antonio, Texas, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

10th Annual European Pharma Congress

Frankfurt, Germany
June 18-19, 2018

9th Global Experts Meeting on Neuropharmacology

Paris, France
June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
July 09-10, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 16-18, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
September 13-14, 2018

7th World Congress on Chromatography

Prague, Czech Republic

Natural Products as Anti-Cancer Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in